Coronary vasomotion has an important role in the regulation of myocardial p
erfusion. During dynamic exercise, normal coronary arteries dilate, whereas
stenotic arteries constrict. This exercise-induced vasoconstriction has be
en associated with the occurrence of myocardial ischemia and has been belie
ved to be the result of endothelial dysfunction, with a reduced release or
production of EDRF, increased sympathetic stimulation, enhanced platelet ag
gregation with release of thromboxane A(2) and serotonin, or a passive coll
apse of the disease-free wall segment within the stenosis (the Bernoulli ef
fect), or a combination of any of these. More recently, it has been realize
d that pharmacological treatment might prevent exercise-induced vasoconstri
ction and, thus, reduce myocardial ischemia and the occurrence of angina pe
ctoris. Vasodilators such as nitrates, calcium antagonists or alpha-recepto
r blockers dilate the coronary arteries and prevent coronary stenosis narro
wing during exercise. In contrast, beta-blocking agents are associated with
coronary vasoconstriction at rest, but - conversely - can induce coronary
vasodilatation during exercise.
Pharmacological treatment in patients with stable angina pectoris may impro
ve myocardial ischemia by reducing pre- and afterload, myocardial contracti
lity, oxygen consumption, and vasomotor tone. However, coronary collateral
perfusion can modify these effects by shunting blood from the non-ischemic
to the ischemic region (collateral flow) or by shunting blood from the isch
emic to the non-ischemic zone (coronary steal phenomenon). Typically, a ste
al phenomenon has been reported in patients receiving either dipyridamole o
r calcium antagonists, whereas a reversed steal has been described after be
ta-blockade, with an increase in contralateral tone shunting blood from the
non-ischemic to the ischemic zone (reverse steal phenomenon). Coron Artery
Dis 11:363-369 (C) 2000 Lippincott Williams & Wilkins.